T2 Biosystems Inc Forward P/E
What is the Forward P/E of T2 Biosystems Inc?
The Forward P/E of T2 Biosystems Inc is -1.64
What is the definition of Forward P/E?
Forward price to earnings ratio is the ratio of a company’s stock price to the company’s estimated earnings per share for the next twelve months.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Forward P/E of companies in the Health Care sector on NASDAQ compared to T2 Biosystems Inc
What does T2 Biosystems Inc do?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Companies with forward p/e similar to T2 Biosystems Inc
- Tiziana Life Sciences Ltd has Forward P/E of -1.76
- Allogene Therapeutics Inc has Forward P/E of -1.74
- Applied Dna Sciences Inc has Forward P/E of -1.72
- Resaas Services has Forward P/E of -1.70
- Contact Gold has Forward P/E of -1.67
- FAT Brands Inc has Forward P/E of -1.66
- T2 Biosystems Inc has Forward P/E of -1.64
- Cotinga Pharmaceuticals has Forward P/E of -1.63
- Osmotica Pharmaceuticals Plc has Forward P/E of -1.61
- Black Diamond Therapeutics Inc has Forward P/E of -1.59
- Proteostasis Therapeutics Inc has Forward P/E of -1.57
- Hepion Pharmaceuticals Inc has Forward P/E of -1.56
- Suzlon has Forward P/E of -1.53